home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

234 rows where filing_period = "second_quarter", filing_year = 2009 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, received_date (date)

issue_code 1

  • PHA · 234 ✖

filing_year 1

  • 2009 · 234 ✖

filing_period 1

  • second_quarter · 234 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
743682 RUBICON ADVISORS, LLC e3fa9c29-7b9e-419f-a67a-d5beb5a109b0 2A RUBICON ADVISORS, LLC 315091 GILEAD SCIENCES 2009 second_quarter PHA H.R. 822, H.R. 1943, H.R. 6114, S-2969   75000   0 0 2009-02-10T20:11:51-05:00
781046 HAMILTON ADVISORS INC. 27d94c41-7ce6-4a38-8f6f-ecc2d591c7bd 2T HAMILTON ADVISORS INC. 400306434 SANOFI-AVENTIS 2009 second_quarter PHA TRICARE HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2009-06-22T11:03:01-04:00
781225 HOLLAND & KNIGHT LLP 3e1d1ba7-0248-442c-8652-01ac059f3e92 Q2 HOLLAND & KNIGHT LLP 18466 NATIONAL HEMOPHILIA FOUNDATION 2009 second_quarter PHA Blood and blood product safety; issues related to blood product approvals. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 40000   0 0 2009-06-25T11:18:07-04:00
781234 HOLLAND & KNIGHT LLP 79423472-9491-465b-86be-f526788b95d5 Q2 HOLLAND & KNIGHT LLP 18466 AMERICAN SOCIETY OF HEMATOLOGY 2009 second_quarter PHA Hematology and Oncology drug research and approval issues. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 20000   0 0 2009-06-25T11:21:11-04:00
781487 PROCESS HANDLER ET AL. FOR HIRE, INC. 6b430242-bc3a-45b9-9270-300e52094e09 2T PROCESS HANDLER ET AL. FOR HIRE, INC. 81830 MR BEVERLY DWAYNE WALKER 2009 second_quarter PHA Several postage-paid postcards addressed to several various U.S. federal executive officials and agencies, several financial houses and the Bristol-Myers Squibb Company and dated June 10, 2009, regarding various unfinished, outstanding matters and concerns. Several postage-paid postcards addressed to all the Members, inclusive, officers, inclusive, operatives, inclusive, et al., inclusive, of the National Security Council of the United States of America et al., inclusive, all the Members, inclusive, officers, inclusive, operatives, inclusive, et al., inclusive, of the United Nations et al., inclusive, via whomever is the current President of the United Nations Security Council et al., inclusive, Deutsche Bank AG, UBS AG and the Bristol-Myers Squibb Company and dated June 10, 2009, regarding various unfinished, outstanding matters and concerns. Central Intelligence Agency (CIA),Defense, Dept of (DOD),Defense Intelligence Agency (DIA),Director of National Intelligence (ODNI),Executive Office of the President (EOP),Federal Bureau of Investigation (FBI),Housing & Urban Development, Dept of (HUD),Joint Chiefs of Staff,Natl Economic Council (NEC),Natl Security Agency (NSA),Natl Security Council (NSC),Office of Policy Development,President of the U.S.,Securities & Exchange Commission (SEC),State, Dept of (DOS),Vice President of the U.S.,White House Office     0 1 2009-06-29T18:34:17-04:00
781607 CYBER SECURITY RESEARCH CONSULTANTS, LLC b7f97e21-0ff2-464e-b9d9-084964932659 Q2 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2009 second_quarter PHA Food and Drug Safety Globalization Act Monitoring Dorgan-Snowe drug reimportation from Canada Health Care Reform HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2009-06-30T15:31:45-04:00
782378 MEREDITH MCGEHEE 3020a205-6efc-4501-bff6-31d814b156cc Q2 MEREDITH MCGEHEE 79858 INTERNATIONAL AIDS VACCINE INITIATIVE 2009 second_quarter PHA funding for programs to develop AIDS vaccine targeted toward the developing world; research and development programs aimed at the AIDS epidemic; tax issues affecting AIDS vaccine programs; patent issues related to vaccine development; implementation of PEPFAR; appropriations for USAID R&D and funding for IAVI HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2009-07-06T11:01:24-04:00
782511 HOLLAND & KNIGHT LLP 6f9c4dff-ca22-43a5-8949-e001873efe7e Q2 HOLLAND & KNIGHT LLP 18466 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2009 second_quarter PHA Issues relating to the biotechnology industry. HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2009-07-06T13:26:29-04:00
783039 RASKY PARTNERS, INC. cebd93fd-41af-44d1-a1ab-b30099be5505 Q2 RASKY PARTNERS, INC. 297410 ELI LILLY AND CO 2009 second_quarter PHA 1548 An Act to amend the public health service act to establish a pathway for the licensure of biosimilar biological products, and for other purposes HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-07-07T16:12:18-04:00
783848 INDEPENDENT PHARMACY COOPERATIVE b474014d-9db2-460f-aec2-e4942dd82766 Q2 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2009 second_quarter PHA Average Manufacturer Price Pharmacy Reimbursement S. 511 and H.R. 616 Access To Durable Medical Equipment Act Antitrust Laws Regarding Pharmacy Benefit Managers Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2009-07-09T10:35:51-04:00
783869 THE KROGER CO. e41b258d-c626-4279-b2a3-9198fd6f26d9 Q2 THE KROGER CO. 88212 KROGER CO 2009 second_quarter PHA S 511 Access to Durable Medical Equipment Act HOUSE OF REPRESENTATIVES,SENATE   145000 0 0 2009-07-09T10:52:03-04:00
784224 PRIME THERAPEUTICS daa597b7-b5da-482d-b2fb-18b157e8fd0c Q2 PRIME THERAPEUTICS 400339576 PRIME THERAPEUTICS 2009 second_quarter PHA HR 1204 "Community Pharmacy Fairness Act of 2009" S._____ "Affordable Health Choices Act" Health care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1427/S 726 "Promoting Innovation and Access to Life-saving Medicine Act" HR 1548 "Pathway for Biosimilars Act" Medicare Part D Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   106701 0 0 2009-07-09T14:32:53-04:00
785001 MR. THEODORE (TED) JONES 600dd5ee-853a-4305-87fe-395718687003 Q2 MR. THEODORE (TED) JONES 20926 PHARMACEUTICAL RESEARCH AND MANUFACTURES OF AMERICA 2009 second_quarter PHA Trade Association for certain Pharmaceutical Companies HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2009-07-10T14:36:46-04:00
786104 JULIE PHILP 2d10c194-aea3-4db0-b37d-69a8994c9be8 Q2 JULIE PHILP 400407928 NATIONAL GRASSROOTS AND COMMUNICATION 2009 second_quarter PHA Medicare and Medicaid issues; antitrust exemption to allow independent pharmacists to negotiate with private insurers and pharmacy benefit managers. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2009-07-13T13:00:10-04:00
786134 THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 14a369d1-1bf6-4881-9efc-1d6b1b9f5092 Q2 THE ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 309377 ASSOCIATION OF COMMUNITY PHARMACISTS CONGRESSIONAL NETWORK 2009 second_quarter PHA Medicare and Medicaid issues relating to pharmacy and reimbursement; HR 1204, an antitrust exemption to allow independent pharmacies to negotiate with private insurers and pharmacy benefit managers. HOUSE OF REPRESENTATIVES,SENATE     0 0 2009-07-13T13:17:25-04:00
786467 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 1a1a7b69-562c-49d9-b4ab-652ee8ed9e68 Q2 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2009 second_quarter PHA Importation of prescription drugs (S. 525/S. 1232/H.R. 1298) Rx Pedigree Methamphetaine/Pseudoephedrine Regulation (S.256/H.R. 2923) Dextromethorphan Regulation (H.R. 1259/S. 1383) Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   240000 0 0 2009-07-13T14:59:30-04:00
786606 MEHLMAN CONSULTING, INC. 883b65a9-6c82-4099-9e40-5a4bca8f65bb Q2 MEHLMAN CONSULTING, INC. 284950 MERCK AND CO INC 2009 second_quarter PHA Support efforts to ensure appropriate access to vaccines and preventive care. Issues related to Medicare, Medicaid, and State Children's Health Insurance Program Coverage. Issues related to The Implementation of the FDAAA of 2007. Issues relating to importation of prescription drugs. Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-07-13T15:35:32-04:00
786694 APTIV, PLC 5f17db0e-af47-4666-a1d2-d1d211ab5210 Q2 APTIV, PLC 49054 APTIV PLC 2009 second_quarter PHA Accessibility of generic drugs e-prescriptions Medical IT Commerce, Dept of (DOC),Defense Advanced Research Projects Agency (DARPA),Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),Federal Aviation Administration (FAA),Federal Motor Carrier Safety Administration,Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Aeronautics & Space Administration (NASA),Pension Benefit Guaranty Corporation (PBGC),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA)   340000 0 0 2009-07-13T16:06:45-04:00
786851 BROWN RUDNICK LLP 3136baec-d2b3-4a5f-9647-d0a05410c229 Q2 BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2009 second_quarter PHA S.525 & H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-07-13T17:09:47-04:00
786960 PARRY, ROMANI, DECONCINI & SYMMS 50285d6d-14b1-4045-bf06-17d9455a0604 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 AMERICAN ASSOCIATION FOR HEALTH FREEDOM 2009 second_quarter PHA Support of legislation and efforts to guarantee access by health professionals and patients to medications such as estriol and other compounded preparations. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-07-13T17:46:22-04:00
787317 DUTKO WORLDWIDE, LLC 14e6683e-1eb5-499f-a70a-8e52a5be9b59 Q2 DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2009 second_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (S. 510). Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-07-14T09:29:50-04:00
787354 EXPRESS SCRIPTS, INC. e2af8004-b6d9-451d-943a-792b0d39fea9 Q2 EXPRESS SCRIPTS, INC. 294416 EXPRESS SCRIPTS, INC. 2009 second_quarter PHA Items related to reverse settlement payments between manufacturers, HR 1706 Changing the definition of first-to-file between manufacturers, S 1315 Items related to oversight of the federal employees health benefit program and its pharmacy benefit Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE   410000 0 0 2009-07-14T09:44:36-04:00
787435 INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) 58478eb4-cb5f-482c-bde9-a49472569896 Q2 INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) 400337570 INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) 2009 second_quarter PHA Pharmacy Issues as they related to compounding pharmacists and pharmacy services/governance. HOUSE OF REPRESENTATIVES,SENATE     0 0 2009-07-14T10:44:41-04:00
787679 CAPITOL HILL CONSULTING GROUP 5ba147d5-40fb-4cce-ab06-4cc3e45f94f1 Q2 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2009 second_quarter PHA Controlled Drug Substances Act (21 USC 13) HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2009-07-14T12:21:26-04:00
788195 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 1cfd67fd-aa9c-454e-b930-08787824d33f Q2 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 58534 ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 2009 second_quarter PHA H.R.444; S. 1239. To amend section 340B of the Public Health Service Act to revise and expand the drug discount program under that section to improve the provision of discounts on drug purchases for certain safety net providers, any language expanding 340B drug discounts to inpatient settings. HOUSE OF REPRESENTATIVES,SENATE   60129 0 0 2009-07-14T15:33:25-04:00
788878 POLICY ADVOCATES 24cd928b-ec83-4772-b635-202b7425e939 Q2 POLICY ADVOCATES 72018 PHOENIX CAPITAL MANAGEMENT LLC 2009 second_quarter PHA Track and monitor Internet Pharmacy Issues. HOUSE OF REPRESENTATIVES,SENATE 17500   0 0 2009-07-15T09:10:00-04:00
788973 SQUIRE PATTON BOGGS 0455782c-d67f-4729-a89f-d4c83d8ce54d Q2 SQUIRE PATTON BOGGS 30906 KERR CORPORATION 2009 second_quarter PHA Issues related to FDA enforcement action against counterfeits of client's medical devices. HOUSE OF REPRESENTATIVES     0 0 2009-07-15T09:54:43-04:00
789046 POLICY DIRECTIONS INC. fb093aee-4aef-41c6-b000-72a9e3196454 Q2 POLICY DIRECTIONS INC. 31747 ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) 2009 second_quarter PHA Antibiotics in animal foods Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. S. 619/HR 1549, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2009-07-15T10:21:26-04:00
789883 PRICEWATERHOUSECOOPERS 96b19b1f-38cd-4041-b9b4-e2a840bdde23 Q2 PRICEWATERHOUSECOOPERS 10764 SCHERING-PLOUGH CORPORATION 2009 second_quarter PHA General issues affecting pharmaceutical companies Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2009-07-15T13:14:28-04:00
790037 UNIVERSITY OF CONNECTICUT 6a0a50f9-2690-462a-a2ca-069df5ac4111 Q2 UNIVERSITY OF CONNECTICUT 39382 UNIVERSITY OF CONNECTICUT 2009 second_quarter PHA H.R.2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues. Public Law 111-8, Omnibus Appropriations Act, FY2009, FDA salaries and expenses; and extramural research related issues. Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA)   60000 0 0 2009-07-15T13:59:32-04:00
790182 EVERGREEN ASSOCIATES, LTD. 8ac718fb-6313-4a6f-aae5-1399413e4ab8 Q2 EVERGREEN ASSOCIATES, LTD. 13984 PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION 2009 second_quarter PHA Risk Communications: Consumer Medication Information, Medication Guides, Patient Package Inserts, Professional Inserts Food & Drug Administration (FDA)     0 0 2009-07-15T14:28:46-04:00
790745 HANCE SCARBOROUGH 31c39ee9-6169-4e00-93ae-8c08003c4f1b 2T HANCE SCARBOROUGH 17443 ALLIANCE FOR PHARMACY COMPOUNDING 2009 second_quarter PHA Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. HOUSE OF REPRESENTATIVES,SENATE 20000   0 1 2009-07-15T16:09:20-04:00
791433 RUBICON ADVISORS, LLC 284fb9b0-8973-4e75-8dd7-4e8e3bc61969 Q2 RUBICON ADVISORS, LLC 315091 INSMED INCORPORATED 2009 second_quarter PHA Generic Biologics S. 1695 Affordable Health Care Choices Act   22500   0 0 2009-07-15T20:18:42-04:00
791435 RUBICON ADVISORS, LLC 71eaaec8-bae2-44ca-af76-c953f1274a66 Q2 RUBICON ADVISORS, LLC 315091 OSMOTICA PHARMACEUTICALS 2009 second_quarter PHA FDA Citizen Petition Reform Affordable Health Choices Act   35000   0 0 2009-07-15T20:21:43-04:00
791436 RUBICON ADVISORS, LLC 7d6025fa-6229-4b15-961a-d5336131f881 Q2 RUBICON ADVISORS, LLC 315091 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2009 second_quarter PHA Physician Payment Sunshine Act S. 2029 Patent Settlements H.R. 1432S. 316 Affordable Health Choices Act   30000   0 0 2009-07-15T20:23:44-04:00
791437 RUBICON ADVISORS, LLC a724b917-2f66-4973-911c-53b77c024e98 Q2 RUBICON ADVISORS, LLC 315091 GILEAD SCIENCES 2009 second_quarter PHA H.R. 822, H.R. 1943, H.R. 6114, S-2969   75000   0 0 2009-07-15T20:24:45-04:00
791438 RUBICON ADVISORS, LLC 971b1128-e9a6-4588-8da3-7aacc12dfae0 Q2 RUBICON ADVISORS, LLC 315091 TEVA PHARMACEUTICALS USA 2009 second_quarter PHA Patent Settlements H.R. 1432 S. 316, Generic Biologics S. 1695 H.R. 5629, Physician Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affordable Health Choices Act   105000   0 0 2009-07-15T20:26:46-04:00
791439 RUBICON ADVISORS, LLC 76f83f2e-296d-4566-a792-11d9c50640d0 Q2 RUBICON ADVISORS, LLC 315091 WATSON PHARMACEUTICALS INC 2009 second_quarter PHA Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S. 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S. 2029   98000   0 0 2009-07-15T20:28:47-04:00
791676 VAN SCOYOC ASSOCIATES b0e8f5ba-1483-4010-99cb-099ed17cc01e Q2 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF CONNECTICUT 2009 second_quarter PHA H.R.2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues. Public Law 111-8, Omnibus Appropriations Act, FY2009, FDA salaries and expenses; and extramural research related issues. Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA) 50000   0 0 2009-07-16T07:51:16-04:00
791692 VAN SCOYOC ASSOCIATES 7a3d16a7-bb0e-443d-b539-f0e6afc3b29d Q2 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE 2009 second_quarter PHA H.R.2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA and USDA funding initiatives. Public Law 111-8, Omnibus Appropriations Act, FY2009, FDA and USDA funding initiatives. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-07-16T07:52:18-04:00
791705 VAN SCOYOC ASSOCIATES e2a303b2-cc61-4b29-9325-15ccc9756bf7 Q2 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF MARYLAND BALTIMORE 2009 second_quarter PHA H.R.2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2010, FDA salaries and expenses; and extramural research related issues. Defense, Dept of (DOD),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-07-16T08:38:25-04:00
792009 THE UNITED STATES PHARMACOPEIAL CONVENTION 6b4f3512-3f86-42ac-ab41-8c40a18fc2ed Q2 THE UNITED STATES PHARMACOPEIAL CONVENTION 400358632 THE UNITED STATES PHARMACOPEIAL CONVENTION 2009 second_quarter PHA -HR 1859/ S 767, "Independent Drug Education & Outreach Act", regarding all provisions, specifically standards relating to academic detailing. -HR 1427/S 726, "Promoting Innovation and Access to Lifesaving Medicine Act, regarding all provisions. -HR 1548, "Pathway for Biosimilars Act", regarding all provisions. -HR 1298/ S 525, "Pharmaceutical Market Access and Drug Safety Act of 2009", regarding all provisions in supporting the FDA and compendial standards for drugs (reimportation and importation). -Issues relating to Heparin, consultation on heparin and compendial standards. -S 882, "Drug and Device Accountability Act of 2009", regarding section 111 in support of compedial modernization. -S 369, "The Preserving Access to Affordable Generic Drugs Act", regarding all provisions. -Consultation regarding exclusivity in drug law. -Information regarding USP General Chapter <1> Injections - labeling on ferrules and cap overseals. -Outreach to House and Senate staff to explain USP's standards setting mission. -Outreach to Administration to explain USP's standards setting mission. -Communications with Congress regarding USP China MOU re: drugs. Congressional Budget Office (CBO),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,President of the U.S.,SENATE   80000 0 0 2009-07-16T09:53:33-04:00
792106 VENABLE LLP 9ee0d817-e398-4f20-9371-c973d28ef127 Q2 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2009 second_quarter PHA General issues affecting the pharmaceutical industry. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2009-07-16T10:10:07-04:00
792133 LONG TERM CARE PHARMACY ALLIANCE 5dac0aff-e115-4515-b222-2f9d657b534a Q2 LONG TERM CARE PHARMACY ALLIANCE 400309443 LONG TERM CARE PHARMACY ALLIANCE 2009 second_quarter PHA Medicare Part D Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   201000 0 0 2009-07-16T10:17:22-04:00
792178 LATHAM & WATKINS LLP efa8a605-72d5-4ef6-968b-67d7bc16f7b7 Q2 LATHAM & WATKINS LLP 22201 ORCHID CHEMICALS & PHARMACEUTICALS LTD 2009 second_quarter PHA Food and Drug Administration policy. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2009-07-16T10:25:10-04:00
792598 CAPITOL COUNSEL LLC 02447af4-8061-4007-a5a6-61f398f4c27e Q2 CAPITOL COUNSEL LLC 313715 CARDINAL HEALTH INC 2009 second_quarter PHA Issues related to pharmaceutical supply chain and distribution,including federal pedigree HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2009-07-16T11:41:02-04:00
792725 AMERICAN COLLEGE OF CLINICAL PHARMACY 5fcdca33-c215-41c4-87ba-278ffad0841f Q2 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2009 second_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare Part B and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   60700 0 0 2009-07-16T12:01:51-04:00
792833 ASSOCIATION FOR ACCESSIBLE MEDICINES 3643f1dc-374e-4143-9f18-321efc7b1e8c Q2 ASSOCIATION FOR ACCESSIBLE MEDICINES 16032 ASSOCIATION FOR ACCESSIBLE MEDICINES 2009 second_quarter PHA Generic Biologics, including but not limited to: H.R.1427, H.R.1548, and S.726 Prescription Drug Safety Counterfeit Drugs/Import Safety/Pedigree, such as: H.R.759 Authorized Generics, including, but not limited to: S.501 and H.R.573 Prescription Drug Importation/Re-Importation Any other matters that relate to access to generic drugs Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR),White House Office   570363 0 0 2009-07-16T12:21:02-04:00
793319 FOOD MARKETPLACE INC. a7f77929-add4-48df-855d-e2bb0b36c915 Q2 FOOD MARKETPLACE INC. 15097 FOOD MARKETPLACE INC 2009 second_quarter PHA HR 616 and S. 511, Access to Durable Medical Equipment Act, to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applied to certain professionals; exempts pharmacists and pharmacies from accreditation requirements in the Medicare Durable Medical Equipment, Prosthetics, Orthotics and Supplies program. S. 256, Combat Methamphetamine Enhancement Act of 2009, letter sent to Sen. Feinstein (D-CA) in support of entire bill. No bill number yet, Senate Health, Education, Lobor and Pension Committee's Affordable Health Choices Act - lobbied Section 213 and 212 of the Act in support of pharmacist provided MTM services and medical home House Tri-Committee Health Care Reform Legislation - Discussion Draft, Section 1841, Pages 708 - 710 - AMP Medicaid Reimbursement Formula. HR 1970 - Preserve Patient Access to Reputable DMEPOS Providers Act, support full text. HR 616 - Access to Durable Medical Equipment Act, support full text. S. 511 - Access to Durable Medical Equipment Act, support full text. Federal Reserve System,HOUSE OF REPRESENTATIVES,SENATE   1116360 0 0 2009-07-16T13:55:53-04:00
793419 WALMART INC. d25339b8-2e07-4f72-bb2f-59e80f1b511e Q2 WALMART INC. 40305 WALMART INC 2009 second_quarter PHA H.R. 1548 & S. 1427 to amend title XIX of the Society Security Act to ensure that individuals eligible for medical assistance under the Medicaid Program continue to have access to prescription drugs, and for other purposes Average Manufacturers Price H.R. 616 & S. 511 to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals H.R. 1970 & S. 956 to amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Consumer Product Safety Commission (CPSC),Council on Environmental Quality (CEQ),Energy, Dept of,Federal Energy Regulatory Commission (FERC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),Natl Security Council (NSC),Office of Natl Drug Control Policy (NDCP),SENATE,State, Dept of (DOS),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office   2580000 0 0 2009-07-16T14:14:52-04:00
793610 MASSACHUSETTS MEDICAL SOCIETY ae64ba7c-f8ec-4895-acd3-8189488c22de Q2 MASSACHUSETTS MEDICAL SOCIETY 23975 MASSACHUSETTS MEDICAL SOCIETY 2009 second_quarter PHA S. 301, Physician Payment Sunshine Act legislation which would require pharmaceutical companies and device manufactures to disclosure gifts and other contributions to physicians HR 1427/S 726 Providing Innovative Access to Life Saving Medicines Act Health Care Reform - Proposals to eliminate tax deductibility for direct to consumer advertising Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   60000 0 0 2009-07-16T14:47:48-04:00
793623 EISAI INC. 5473fcc5-ea90-40c3-896d-3ad3e3af1eca Q2 EISAI INC. 400321512 EISAI INC. 2009 second_quarter PHA Biosimilars, Follow-on biologics H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act S. 301 Physician Payments Sunshine Act of 2009 HOUSE OF REPRESENTATIVES,SENATE   570000 0 0 2009-07-16T14:50:54-04:00
793725 THE OB-C GROUP, LLC d05b610f-6f7c-4d26-afe9-7e211d37ced7 Q2 THE OB-C GROUP, LLC 29802 ELI LILLY 2009 second_quarter PHA HR 1548, Pathway for Biosimilars Act: entire bill. No specific bill number: matters relating to pharmaceutical manufacturers in Health Care Reform. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-07-16T15:05:15-04:00
793952 AVENUE SOLUTIONS 0f78db50-8a54-4905-94d2-c69e465f42bf Q2 AVENUE SOLUTIONS 72111 AETNA 2009 second_quarter PHA Senate HELP Committee Draft Affordable Health Choices Act (Kennedy) - generic biologics; H.R. 1204, Community Pharmacy Fairness Act (Weiner) - antitrust exemption for pharmacies; H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act (Waxman) - generic biologics; H.R. 1548, Pathway for Biosimilars Act (Eshoo) - generic biologics; H.R. 1706, Protecting Consumer Access to Generic Drugs Act (Rush) generic drugs; S. 369, Preserve Access to Affordable Generics Act (Kohl) generic drugs; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act (Schumer) generic biologics. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 60000   0 0 2009-07-16T15:46:23-04:00
793961 AVENUE SOLUTIONS 5ec6d7c6-a62d-45c0-83e2-444e2b22e699 Q2 AVENUE SOLUTIONS 72111 BLUE CROSS BLUE SHIELD ASSOCIATION 2009 second_quarter PHA Senate HELP Committee Draft Affordable Health Choices Act (Kennedy) - generic biologics; H.R. 1204, Community Pharmacy Fairness Act (Weiner) - antitrust exemption for pharmacies; H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act (Waxman) - generic biologics; H.R. 1548, Pathway for Biosimilars Act (Eshoo) - generic biologics; H.R. 1706, Protecting Consumer Access to Generic Drugs Act (Rush) generic drugs; S. 369, Preserve Access to Affordable Generics Act (Kohl) generic drugs; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act (Schumer) generic biologics. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 80000   0 0 2009-07-16T15:46:30-04:00
793986 AVENUE SOLUTIONS 2d86c89f-75e4-4358-b0e7-1d7ce9c73209 Q2 AVENUE SOLUTIONS 72111 HEALTHCARE LEADERSHIP COUNCIL 2009 second_quarter PHA Senate HELP Committee Draft Affordable Health Choices Act (Kennedy) - generic biologics; H.R. 1204, Community Pharmacy Fairness Act (Weiner) - antitrust exemption for pharmacies; H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act (Waxman) - generic biologics; H.R. 1548, Pathway for Biosimilars Act (Eshoo) - generic biologics; H.R. 1706, Protecting Consumer Access to Generic Drugs Act (Rush) generic drugs; S. 369, Preserve Access to Affordable Generics Act (Kohl) generic drugs; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act (Schumer) generic biologics. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 60000   0 0 2009-07-16T15:49:39-04:00
793996 AVENUE SOLUTIONS 0a77c40d-be47-4a37-b8b8-f49eadefe9df Q2 AVENUE SOLUTIONS 72111 EXPRESS SCRIPTS INC 2009 second_quarter PHA Senate HELP Committee Draft Affordable Health Choices Act (Kennedy) generic biologics; H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act (Waxman) generic biologics; H.R. 1548, Pathway for Biosimilars Act (Eshoo) generic biologics; H.R. 1706, Protecting Consumer Access to Generic Drugs Act (Rush) generic drugs; S. 369, Preserve Access to Affordable Generics Act (Kohl) generic drugs; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act (Schumer) generic biologics. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 80000   0 0 2009-07-16T15:50:46-04:00
794022 AVENUE SOLUTIONS 110e150d-6353-4659-a02c-35c5891cf64f Q2 AVENUE SOLUTIONS 72111 UNITEDHEALTH GROUP INC 2009 second_quarter PHA Senate HELP Committee Draft Affordable Health Choices Act (Kennedy) - generic biologics; H.R. 1204, Community Pharmacy Fairness Act (Weiner) - antitrust exemption for pharmacies; H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act (Waxman) - generic biologics; H.R. 1548, Pathway for Biosimilars Act (Eshoo) - generic biologics; H.R. 1706, Protecting Consumer Access to Generic Drugs Act (Rush) generic drugs; S. 369, Preserve Access to Affordable Generics Act (Kohl) generic drugs; S. 726, Promoting Innovation and Access to Life-Saving Medicine Act (Schumer) generic biologics. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office 60000   0 0 2009-07-16T15:53:00-04:00
794211 PARRY, ROMANI, DECONCINI & SYMMS 75931ae7-5d6b-4658-b454-55fb7269b650 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 SUNOVION PHARMACEUTICALS INC (FORMERLY SEPRACOR INC ) 2009 second_quarter PHA No specific legislation or bills introduced at this time. Medicare reimbursement issues. HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2009-07-16T16:27:04-04:00
794244 FABIANI & COMPANY 10c785e8-7339-4959-a8e6-772e20d8d3f1 Q2 FABIANI & COMPANY 72576 ALNYLAM PHARMACEUTICALS 2009 second_quarter PHA S.515 Patent Reform Act Provisions relating to the apportionment of damages HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-07-16T16:31:58-04:00
794333 TEVA PHARMACEUTICALS USA, INC. 31753018-5dcf-4e63-8003-561f638953f8 Q2 TEVA PHARMACEUTICALS USA, INC. 76695 TEVA PHARMACEUTICALS USA INC 2009 second_quarter PHA S. 301, Physician Payments Sunshine Act of 2009; H.R. 1859 and S. 767, Independent Drug Education and Outreach Act of 2009; H.R. 1427 and S. 726, Promoting Innovation and Access to Life-Saving Medicine Act; and H.R. 1548, Pathway for Biosimilars Act; legislation and proposals relating to "doughnut hole" impact; and FDA implementation of the Food & Drug Administration Amendments Act ("FDAAA"). Commerce, Dept of (DOC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE,U.S. Trade Representative (USTR)   840000 0 0 2009-07-16T16:48:42-04:00
794511 US STRATEGIES d2f6c8dc-a633-490f-a532-f2ca72265d59 Q2 US STRATEGIES 38825 NOVOLOGIX (FORMERLY ANCILLARY CARE MANAGEMENT) 2009 second_quarter PHA Medicare and Medicaid provisions relating to pharmacy and medication management policies HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2009-07-16T17:18:28-04:00
794687 CENCORA, INC. 1cbd0723-9a91-4752-b289-1607ae1981f7 Q2 CENCORA, INC. 293756 CENCORA, INC. 2009 second_quarter PHA H.R. 1392 and S. 1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. HOUSE OF REPRESENTATIVES,SENATE   226700 0 0 2009-07-16T17:44:38-04:00
794709 PODESTA GROUP, INC. a44743f4-f424-4510-a63c-4501c159c087 Q2 PODESTA GROUP, INC. 31680 GENENTECH 2009 second_quarter PHA H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act of 2009 S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2009-07-16T17:50:46-04:00
794791 PODESTA GROUP, INC. 54fbdc94-5ca9-4d76-8a64-4d3bf92a641a Q2 PODESTA GROUP, INC. 31680 THE UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER 2009 second_quarter PHA Patient safety, animal research, clinical trials, scientific misconduct, conflict of interest S. 717 21st Century Cancer ALERT (Access to Life Saving Early detection, Research and Treatment) Act HOUSE OF REPRESENTATIVES,SENATE 110000   0 0 2009-07-16T18:04:31-04:00
794831 PODESTA GROUP, INC. 7462969f-5705-4b8a-a024-b879923ced73 Q2 PODESTA GROUP, INC. 31680 WINNING STRATEGIES WASHINGTON LLC 2009 second_quarter PHA Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies - Competitive Bidding Program Issues Kennedy Healthcare Reform Bill House Tri Committee Healthcare Reform Bill Tri Caucus Healthcare Reform Bill Senate Finance Healthcare Reform Bill H.R. 616 Pharmacists Exemption to CMS DME Requirements Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2009-07-16T18:11:48-04:00
795464 THE RUSSELL GROUP, INC. f4ba6722-1cc6-43be-a4a9-0d478c8e0fa0 Q2 THE RUSSELL GROUP, INC. 22688 GENERIC PHARMACEUTICAL ASSOCIATION 2009 second_quarter PHA Issues relative to generic pharmaceuticals and generic biologics; H.R. 2997, S. 1406 - 2010 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Bill (Title VI - Related Agencies and Food and Drug Administration Department of Health and Human Services); H.R. 1427, S. 726 - Promoting Innovation and Access to Life-Saving Medicine Act (entire bill) Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2009-07-17T09:03:09-04:00
795599 ANIMAL HEALTH INSTITUTE 351dfa52-f53b-46ca-a5fd-55b01db2db06 Q2 ANIMAL HEALTH INSTITUTE 4037 ANIMAL HEALTH INSTITUTE 2009 second_quarter PHA Antimicrobial Resistance; HR 1549, S619, Preservation of Antibiotics for Medical Treatment Act; HR2400, Strategies to Address Antimicrobial Resistance Act; S510, FDA Food Safety Modernization Act; HR2749, Food Safety Enhancement Act of 2009 Agriculture, Dept of (USDA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2009-07-17T09:24:59-04:00
795994 PARRY, ROMANI, DECONCINI & SYMMS 15204b09-19f3-464f-bb1c-ee5a7e42d275 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2009 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2009-07-17T10:33:49-04:00
796092 MOFFETT GROUP, LLC 798078c7-1349-4e25-ad16-b40e3179bacc Q2 MOFFETT GROUP, LLC 82578 BOEHRINGER INGELHEIM PHARMECEUTICAL 2009 second_quarter PHA Phamaceutical issues, especially with respect to the House Energy and Commerce Committee. HOUSE OF REPRESENTATIVES,SENATE 38568   0 0 2009-07-17T10:48:53-04:00
796104 AMYLIN PHARMACEUTICALS 45b0dc17-9bda-4fad-a06a-2036b6e82f28 Q2 AMYLIN PHARMACEUTICALS 308536 AMYLIN PHARMACEUTICALS 2009 second_quarter PHA Payment disclsoure regulations in the Physician Payments Sunshine Act of 2009 Data exclusivity provisions in H.R. 1548, Pathway for Biosimilars Act Data eclsuivity provisions in Promoting Innovation and Access to Life-Saving Medicine Act (H.R. 1427,S. 726) Regulatory provisions in the Food and Drug Administration Globalization Act of 2009 (H.R. 759) Drug Importation/Drug Safety Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   320000 0 0 2009-07-17T10:50:00-04:00
796155 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 30d2bf75-8754-44a9-b75e-34c866c68ee0 Q2 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2009 second_quarter PHA Communication with FDA and HHS regarding standards for securing the drug supply chain and the National Drug Code system. Communication with the Office of the National Coordinator regarding "Draft Use of Electronic Health Records in Clinical Research. Communication with Food and Drug Administration on evaluation of consumer medication information. Communication with Health Resources and Services Administration on National Quality Forum priorities and pharmacist residency training and workforce issues. Comments to Office of the National Coordinator regarding health information technology extension program. Communication with Drug Enforcement Administration regarding implementation of Ryan Haight Online Pharmacy Consumer Protection Act of 2008. Communication with Centers for Medicare and Medicaid Services regarding anticoagulation clinic billing issue. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE,White House Office   250000 0 0 2009-07-17T10:55:12-04:00
796222 JOHNS HOPKINS UNIVERSITY e21c8f48-a2e8-4492-ba47-a559a2888f5d Q2 JOHNS HOPKINS UNIVERSITY 20664 JOHNS HOPKINS UNIVERSITY 2009 second_quarter PHA H.R.444: 340B Program Improvement and Integrity Act of 2009. Issues regarding extending 340B outpatient pharmaceutical discount to the inpatient setting. HOUSE OF REPRESENTATIVES,SENATE   230000 0 0 2009-07-17T11:04:33-04:00
796393 PARRY, ROMANI, DECONCINI & SYMMS ecbfb0bb-5987-44d6-b58b-d86e7781bca1 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 INTL ACADEMY OF COMPOUNDING PHARMACISTS 2009 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2009-07-17T11:23:23-04:00
796653 KNIGHT CAPITOL CONSULTANTS 3f1fab9a-f61a-4960-a863-2c057b9a4b60 Q2 KNIGHT CAPITOL CONSULTANTS 40036301 SANOFI US SERVICES INC (FORMERLY KNOWN AS "SANOFI-AVENTIS U S INC ) 2009 second_quarter PHA Adequacy of Appropriations for the Food and Drug Administration (S. 1406) HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-07-17T11:58:16-04:00
796727 AARP 70494fea-7c0c-40eb-adbe-98714651857b Q2 AARP 1694 AARP 2009 second_quarter PHA S.525/H.R. 1298, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. H.R.2997 Agriculture, Rural Development, FDA and related agencies Appropriations bill for FY2010-Lobbied in support of funding for the Commodity Supplemental Food Program and FDA Office of Generic Drugs, rural housing assistance and repair. Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Energy, Dept of,Federal Communications Commission (FCC),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of Management & Budget (OMB),Office of the Vice President of the United States,Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office   5300000 0 0 2009-07-17T12:05:18-04:00
796755 DLA PIPER LLP (US) 4e22dd7c-df81-4dbe-ba73-4c3a54e8cbb0 Q2 DLA PIPER LLP (US) 76855 SANOFI PASTEUR 2009 second_quarter PHA Pandemic influenza, biodefense, and other vaccine-related issues. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-07-17T12:07:32-04:00
796789 ASSOCIATION OF NATIONAL ADVERTISERS, INC. d2980662-c527-4e81-bf39-f6803e56f295 Q2 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 4653 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 2009 second_quarter PHA Proposals to place a moratorium on prescription drug advertising and requiring a "fair balance" between risk and benefit information in prescription drug advertisements Proposals to extend FDA authority to over-the-counter drug advertisements Federal Communications Commission (FCC),Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE   240000 0 0 2009-07-17T12:12:58-04:00
796984 TARPLIN, DOWNS & YOUNG, LLC a54422aa-7e30-47ba-9c38-973b65d3529b Q2 TARPLIN, DOWNS & YOUNG, LLC 304736 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2009 second_quarter PHA ** see addendum page Import Safety H.R. 759 - Food and Drug Administration Globalization Act of 2009 S. 510 - FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 - Pharmaceutical Market Access Act of 2009 ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety HOUSE OF REPRESENTATIVES,SENATE,White House Office 70000   0 0 2009-07-17T12:35:02-04:00
797083 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION d0fdaedd-5785-4b6e-92eb-2dcc8e843a81 Q2 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 31348 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION 2009 second_quarter PHA H.R. 1204 - Community Pharmacy Fairness Act Electronic Prescribing Mail Order Pharmacy Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE   250327 0 0 2009-07-17T12:47:35-04:00
797210 PARRY, ROMANI, DECONCINI & SYMMS 9a0f48f4-d93f-4bc8-815f-4d2356c0bf98 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2009 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2009-07-17T12:58:29-04:00
797337 PARRY, ROMANI, DECONCINI & SYMMS 615bb9ea-6e96-4d33-9ae9-c2720e1121f5 Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2009 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2009-07-17T13:10:07-04:00
797405 KIRKLAND & ELLIS LLP 8f91d315-a1aa-4994-9d2f-d06a2cc372b1 Q2 KIRKLAND & ELLIS LLP 21745 TEVA PHARMACEUTICALS USA 2009 second_quarter PHA House and Senate legislation on biologic medicines. HOUSE OF REPRESENTATIVES,SENATE     0 0 2009-07-17T13:17:32-04:00
797409 PARRY, ROMANI, DECONCINI & SYMMS c0a08309-cb5c-41e6-864f-0a801a57664c Q2 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2009 second_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2009-07-17T13:18:34-04:00
797467 TARPLIN, DOWNS & YOUNG, LLC 2e9b9170-4e08-4901-b405-f197972ed27e Q2 TARPLIN, DOWNS & YOUNG, LLC 304736 HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) 2009 second_quarter PHA **see addendum page Importation of prescription drugs (S. 525/H.R. 1298/S. 1232) RX Pedigree Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923) Dextromethorphan Regulaton (H.R. 1259/S. 1383) HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2009-07-17T13:26:15-04:00
797701 TARPLIN, DOWNS & YOUNG, LLC 7b05d455-46fd-40d2-9e64-a01b1a9542ef Q2 TARPLIN, DOWNS & YOUNG, LLC 304736 PHRMA 2009 second_quarter PHA **see addendum page Import Safety H.R. 759 - Food and Drug Administration Globalization Act of 2009 S. 510 - FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 - Pharmaceutical Market Access Act of 2009 ***, no specific bill(s), prescription drug importation, import safety HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2009-07-17T13:48:50-04:00
798002 PD FRAZER CONSULTING, INC. 8666c1d6-fd15-49c3-935b-6e732a64f73b Q2 PD FRAZER CONSULTING, INC. 65998 CANADA INTERNATIONAL PHARMACY ASSOCIATION 2009 second_quarter PHA Monitor the development of proposed bills on the importation of prescription drugs HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2009-07-17T14:16:01-04:00
798197 MCDERMOTT WILL & SCHULTE LLP dc43dfad-3538-4154-9fc3-cd7285efe01f Q2 MCDERMOTT WILL & SCHULTE LLP 24338 RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION 2009 second_quarter PHA Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-07-17T14:33:48-04:00
798292 INDEPENDENCE BLUE CROSS 9783509a-a2cb-495f-a8b3-9d0c8124de5e Q2 INDEPENDENCE BLUE CROSS 19172 INDEPENDENCE BLUE CROSS 2009 second_quarter PHA Biogenerics/Generic Biologies: HR1427 "Promoting Innovation and Access to Life-Saving Medicine Act" Carve out of FEBHBP Rx benefits HOUSE OF REPRESENTATIVES,SENATE     0 0 2009-07-17T14:39:31-04:00
798329 THE ACCORD GROUP 94376c49-e89b-49c7-95fd-0f32eb0ae692 Q2 THE ACCORD GROUP 42785 CITIZENS FOR SUN PROTECTION 2009 second_quarter PHA Final promulgation of FDA sunscreen monograph Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE     0 0 2009-07-17T14:43:53-04:00
798419 THE DUBERSTEIN GROUP INC. 1496e54e-5d39-43f0-872e-46f86f3d94c8 Q2 THE DUBERSTEIN GROUP INC. 12675 AMERICA'S HEALTH INSURANCE PLANS 2009 second_quarter PHA Antitrust exemption for pharmacies - HR 1204, To ensure and foster continued patient safety and quality of care by making the antitrust laws apply to negotiations between groups of independent pharmacies and health plans and health insurance issuers (including health plans under parts C and D of the Medicare Program) in the same manner as such laws apply to protected activities under the National Labor Relations Act. Generic biologics - HR 1427, To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes; HR 1548, To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes; S 726, A bill to amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes; draft legislation re this issue (HELP/Kennedy Affordable Health Choices). Generic drugs - HR 1706, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes; S 369, A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2009-07-17T14:52:39-04:00
798505 MCAPITOL MANAGEMENT 155c62e7-66ba-4a32-b14a-908b494abdbe Q2 MCAPITOL MANAGEMENT 78471 MINNESOTA THERMAL SCIENCE 2009 second_quarter PHA vaccines HOUSE OF REPRESENTATIVES 20000   0 0 2009-07-17T14:57:07-04:00
798636 THE DUBERSTEIN GROUP INC. cda69274-005c-4cdc-a976-b3b916053f1d Q2 THE DUBERSTEIN GROUP INC. 12675 SUPERVALU 2009 second_quarter PHA Healthcare reform and specifically pharmacy issues - Proposed legislation re these issues Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2009-07-17T15:11:13-04:00
798861 ALCALDE & FAY bf929a4e-150f-458f-bf28-eb46f5aec1b9 Q2 ALCALDE & FAY 818 XSTREAM SYSTEMS, INC. 2009 second_quarter PHA Bringing awareness of the pharmaceutical authentication product to Committees of Congress and federal agencies; Seek to include an authentication provision in legislation addressing counterfeit drugs, pharmaceutical importation, and pharmaceutical distribution including H.R.1298, S.80, and S.525 Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,Veterans Affairs, Dept of (VA) 10000   0 0 2009-07-17T15:36:11-04:00
798930 FABIANI & COMPANY bd604ec7-d444-484b-8b83-f4d67317ca5e Q2 FABIANI & COMPANY 72576 ACORDA THERAPEUTICS, INC. 2009 second_quarter PHA Educate members and staff about Acordas products. Secure funding through the annual appropriation process for research. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2009-07-17T15:41:41-04:00
799002 TARPLIN, DOWNS & YOUNG, LLC ffd60242-896f-4b21-adff-627347584e3d Q2 TARPLIN, DOWNS & YOUNG, LLC 304736 WYETH 2009 second_quarter PHA **see addendum page Biosimilars S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - the Pathway for Biosimilars Act Import Safety H.R. 759 - Food and Drug Administration Globalization Act of 2009 S. 510 - FDA Food Safety Modernization Act ***, no specific bill(s), Biosimilars, Drug Safety, Prescription Drug Importation, Import Safety, Compounding HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2009-07-17T15:47:56-04:00
799018 PODESTA GROUP, INC. 2181ffea-c41e-4457-a482-ccef97ed5c0a Q2 PODESTA GROUP, INC. 31680 BRISTOL-MYERS SQUIBB 2009 second_quarter PHA H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation/Drug Safety Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-07-17T15:48:14-04:00
799048 PODESTA GROUP, INC. 52acf3dd-b128-46ba-8d33-c37e8bf15ab4 Q2 PODESTA GROUP, INC. 31680 EISAI INC. 2009 second_quarter PHA H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-07-17T15:52:31-04:00
799073 PODESTA GROUP, INC. d90cf385-4edf-41d7-84eb-3f6e614154a0 Q2 PODESTA GROUP, INC. 31680 MILLENNIUM PHARMACEUTICALS INC 2009 second_quarter PHA H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act S. 717 21st Century Cancer ALERT (Access to Life Saving Early detection, Research and Treatment) Act Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2009-07-17T15:54:44-04:00
799147 PODESTA GROUP, INC. 3766470d-f8a6-4751-85ce-4693169e207e Q2 PODESTA GROUP, INC. 31680 NOVO NORDISK INC 2009 second_quarter PHA H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 1232 Pharmaceutical Market Access and Drug Safety Act of 2009 Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 60000   0 0 2009-07-17T16:01:16-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 2706.234ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API